Tirzepatide – 10mg

Tirzepatide is a dual incretin peptide that activates both GLP-1 (glucagon-like peptide-1)
and GIP (glucose-dependent insulinotropic polypeptide) receptors.
This dual mechanism has positioned it as a breakthrough compound for research into
weight management, glycemic regulation, and lipid metabolism.
Its balanced receptor activity makes it highly valuable for advanced metabolic studies.

Potential Research Benefits

• Explored for weight management & appetite regulation
• Studied for improving glycemic control
• Supports insulin sensitivity research
• Dual receptor activity: GLP-1 & GIP

Scientific Background

Tirzepatide’s ability to target both incretin receptors provides synergistic effects
beyond single-agonist compounds. Research suggests it enhances satiety, reduces caloric intake,
and improves glucose metabolism. Early studies also highlight potential benefits in lipid
regulation and energy balance, making it an exciting candidate for metabolic disorder research.

Product Details

• Compound: Tirzepatide
• Form: Lyophilized Powder
• Amount: 10mg per vial
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption